Table 1.
Treatment 1 | n | Median Survival (days) | Increase in Survival 2 (%) |
---|---|---|---|
Vehicle | 7 | 10.5 | 0 |
Gemcitabine | 11 | 15.0 | 43 |
PEGPH20 | 10 | 9.0 | 0 |
Gemcitabine + PEGPH20 | 11 | 28.5 | 271 |
1 Methods are described in Jacobetz et al. [11]; 2 Gemcitabine versus combination of gemcitabine and PEGPH20 (p = 0.002).